SavedAdd your journal

Journals / Journal of Clinical and Analytical Medicine / 2016 / Cilt: 7 - Sayı: 1

Transüretral Prostatektomi Uygulanan Hastalarda Üriner Enfeksiyon için Risk Faktörleri

Risk Factors for Urinary Tract Infections in Patients Who Underwent Transurethral Prostatectomy

Bülent GÜNLÜSOY
Tansu DEĞİRMENCİ
Evrim Emre AKSOY
Tufan SÜELÖZGEN
Gökçen GÜRKÖK BUDAK
A Emrah SONBAHAR
Salih BUDAK
Pages
32–34
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Especially the patients who were preoperative catheterization should be followed up after the treatment for postoperative infection.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Transurethral resection of prostate (TURP) is still the gold standard in the surgical treatment of benign prostatic hyperplasia (BPH).
📊
Key Findings & Data:Material and Method: A total of 175 patients with a mean age of 67.5±14.1 years ( ranged from 49 to 87 years) underwent transurehral prostatectomy for BPH in between January 2008 and June 2009.
💡
Conclusion & Impact:Especially the patients who were preoperative catheterization should be followed up after the treatment for postoperative infection.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Transurethral resection of prostate (TURP) is still the gold standard in the surgical treatment of benign prostatic hyperplasia (BPH). Urinary tract infection is an unwilling complication after the procedure. The aim of this study is to evaluate the risk factors which are responsable for the occurrence of nosocomial urinary system infection (NUSI) after TURP. Material and Method: A total of 175 patients with a mean age of 67.5±14.1 years ( ranged from 49 to 87 years) underwent transurehral prostatectomy for BPH in between January 2008 and June 2009. After the patients were divided two groups as NUSI and non-NUSI, Analyzse of the clinical parameters of preoperative PSA, previous prostate biopsy, operation time, resected tissue weight, hospitalization period and preoperative catheterization with the nosocomial urinary system infections was done. Results: NUSI was found in thirty-four (19.4%) patients. Preoperative catheterization (p=0.01) were found as the statistically significant risk factors in the group with nosocomial USI. There was no statistically significant correlation between the PSA, prostate biopsy, operation time, hospitalization period and resected tissue weight with the development of postoperative NUSI. Discussion: The patients with catheterization who are candidates of transurethral prostatectomy for the treatment of BPH should be examined detaily preoperatively period. Especially the patients who were preoperative catheterization should be followed up after the treatment for postoperative infection.

Özet

Amaç: Transüretral prostat rezeksiyonu (TURP) benign prostat hiperplazisinin (BPH) cerrahi tedavisinde hala altın standarttır. Üriner sistem enfeksiyonu bu işlemin arzu edilmeyen komplikasyonlarından biridir. Bu çalışmanın amacı TURP sonrası gelişen nozokomiyal üriner sistem enfeksiyonların oluşmasından sorumlu olan risk faktörlerini incelemektir. Gereç ve Yöntem: Ocak 2008-Haziran 2009 tarihleri arası BPH tanısıyla TUR-P uygulanan yaş ortalaması 67.5±14.1 (49-87 arası) olan 175 hasta çalışmaya dahil edildi. Hastalar nozkomiyal üriner enfeksiyonu olanlar (ÜSE) ve olmayanlar şeklinde 2 gruba ayrıldı. Gruplar preoperatif PSA düzeyleri, prostat biyopsisi, operasyon süresi, rezeke edilen doku miktarı, hastanede kalış süresi ve preoperatif kataterizasyon açısından karşılaştırıldı. Bulgular: Otuzdört (%19,4) hastada nozokomiyal ÜSE saptandı. Nozokomiyal ÜSE grubunda preoperatif kataterizasyonu (p=0,01) risk faktörü açısından istatistiksel olarak anlamlı bulduk. PSA, prostat biyopsisi, operasyon süresi, hastanede kalış süresi ve rezeke edilen doku miktarıyla postoperatif nozokomiyal ÜSE arasında anlamlı bir ilişki tespit etmedik. Tartışma: BPH nedeniyle TURP planlanan kataterizasyonu olan hastalar ayrıntılı biçimde incelenmelidir. Özellikle de preoperatif dönemde kataterizasyonlu hastalar operasyon sonrası enfeksiyon açısından yakından takip edilmelidir.

🔖

Cite This Article

GÜNLÜSOY, B., DEĞİRMENCİ, T., AKSOY, E. E., SÜELÖZGEN, T., BUDAK, G. G., SONBAHAR, A. E., BUDAK, S. (2022). Transüretral Prostatektomi Uygulanan Hastalarda Üriner Enfeksiyon için Risk Faktörleri. Journal of Clinical and Analytical Medicine, Cilt: 7 - Sayı: 1, 32–34. https://ajindex.com/articles/560896

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Neal DE. The morbidity of transurethral resection of the prostate. Curr Opin Urol 1996;6:147-50.
  2. Wendt-Nordahl G, Bucher B, Hacker A, Knoll T, alken P, Michel MS. Improvement in mortality and morbidity in transurethral resection of the prostate over 17 years in a single center. J Endourol 2007;21:1081-7. Sayek İ. The use of prophylactic antibiotics in surgery. İnfeksiyon Bülteni 1996;1:74-7. McVary KT. BPH: epidemiology and comorbidities. Am J Manag Care 2006;12:122-8.
  3. Knopf HJ, Funke PJ. Signifance of bacterial prostatic colonization for noso- comial urinary tract infections after transurethral prostate resection. Urologe A 2000;39:432-5.
  4. Colau A, Lucet JC, Rufat P, Botta H, Benoit G, Jardin A. Incidence and risk factors of bacteriuria after transurethral resection of the prostate. Eur Urol 2001;39:272- 6. Holtgrewe HL, Ackermann R, Bay-Nielsen H, Boyle P, Carlsson P, Coast J, et al. Report from the Committee on the Economics of BPH. Third international consul- tation on benign prostatic hyperplasia (BPH). Jersey: Scientific Communication In- ternational 1996: 51-70.
  5. Meigs JB, Barry MJ. Natural history of benign prostatic hyperplasia. Textbook of benign prostatic hyperplasia. Oxford: Isis Medical Media 1996:125-35. Boyle P. Epidemiology of benign prostatic hyperplasia: risk factors and concomi- tance with hypertension. Br J Clin Pract 1994;74:18-22.
  6. Garner JS, Jarvis WR, Emori TG, Horon TC. CDC definitions nosocomial Infecti- ons. Am. J Infect Control 1988;16:128-40.
  7. Mebust WK, Peter PC.Transuretral prostatectomy:Immediate and post- operative complications. J Urol 1989;141:243-7.
  8. Pestollozi DM, Boss HP, Knonagel H.Infectious complications after transureth- ral resection. Helv Act Chir 1992;59:497-500.
  9. Emberton M, Harrison M, Williams RE. The clinical management of patients du- ring hospital admission. Br J Urol 1995;75:301-16. Thorpe AC,Cleary R,Coles J,Vernon S. Deaths and complications following prostatectomy in 1400 men in the northern region. Br J Urol 1994;74:559-65. Burke JP. Infection control: a problem for patient safety. N Engl J Med 2003; 348: 651-6.
  10. Budak GG, Budak S, Arı A, Özgenç O. Research for the Agents of the Urinary In- fection Resistant to Multiple Antibiotics and Risk Factors. J Clin Anal Med 2013; DOI:10.4328/JCAM.1892. Özorak A, Hoscan MB, Soyupek S,Oksay T, Güzel A, Öztürk AS, et al. Ciprofloxasin-Ceftriaxone Combination Prophylaxis for Prostate Biopsy: Infective Complications. J Clin Anal Med 2013; DOI:10.4328/JCAM.2096. El Bas